Page last updated: 2024-08-25

5-hydroxymethylcytosine and Nevus, Pigmented

5-hydroxymethylcytosine has been researched along with Nevus, Pigmented in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzer, BL; Essner, R; Frishberg, DP; Huynh, CAT; Shon, W; Siref, AB1
Urso, C1
Ashida, A; Hayashi, K; Kiniwa, Y; Koga, H; Ogawa, E; Okuyama, R; Takazawa, Y; Uchiyama, A; Uchiyama, R; Uhara, H1
Burns, KH; Rodić, N; Sharma, R; Taube, JM; Zampella, J1
Cook, M; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Wang, TJ; Xu, S; Zhan, Q1
Fraitag, S; Hohl, D; Pavlova, O1
Bresler, SC; Fletcher, CD; Frank, AH; Granter, SR; Hu, NR; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Saw, RP; Scolyer, RA; Vilain, RE; Xu, S1

Other Studies

7 other study(ies) available for 5-hydroxymethylcytosine and Nevus, Pigmented

ArticleYear
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
    Journal of cutaneous pathology, 2019, Volume: 46, Issue:4

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Skin Neoplasms; Staining and Labeling

2019
Certain and uncertain malignant potential in melanocytic skin neoplasms.
    Journal of cutaneous pathology, 2019, Volume: 46, Issue:9

    Topics: 5-Methylcytosine; Biomarkers; Humans; Nevus, Pigmented; Skin Neoplasms

2019
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
    Journal of dermatological science, 2014, Volume: 73, Issue:2

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Keratinocytes; Male; Melanoma; Middle Aged; Nevus, Epithelioid and Spindle Cell; Nevus, Pigmented; Skin Neoplasms

2014
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
    Journal of cutaneous pathology, 2015, Volume: 42, Issue:11

    Topics: 5-Methylcytosine; Cytosine; Diagnosis, Differential; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Melanocytes; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tissue Array Analysis

2015
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Small Cell; Cytosine; Epigenomics; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Nevus, Pigmented; Prognosis; Skin Neoplasms; Young Adult

2015
5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:12

    Topics: 5-Methylcytosine; Adult; Analysis of Variance; Biopsy, Needle; Cohort Studies; Diagnosis, Differential; Disease Progression; Dysplastic Nevus Syndrome; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Skin Neoplasms

2016
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
    Journal of cutaneous pathology, 2017, Volume: 44, Issue:3

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nevus, Pigmented; Retrospective Studies; Skin Neoplasms; Young Adult

2017